Vernalis plc today announces its decision to cease further investment in V3381. An interim review of data from the small pilot study in chronic cough being undertaken in collaboration with Professor ...

RELX PLC (the “Company”) announces in compliance with the UK and EU Market Abuse Regulations that it will implement an irrevocable, non-discretionary programme to repurchase its ordinary shares ...

LEEDS, England, July 25, 2019 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on its oncology programmes.

LONDON, UK / ACCESSWIRE / June 29, 2023 / Poolbeg Pharma (AIM:POLB, OTCQB:POLBF, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company focusing on infectious and other prevalent ...

In part one of this series, we looked at the PLC’s internal architecture, briefly discussed Ladder Logic programming, Human-Machine Interfaces, advantages of the PLC’s ability to react consistently ...

LONDON, UK / ACCESSWIRE / November 9, 2020 / Anglo Pacific Group PLC ("Anglo Pacific", the "Company" or the "Group") (LSE:APF)(TSX:APY), is pleased to announce that following the purchase of ordinary ...

Kainos Group plc ( ($GB:KNOS) ) has issued an announcement. Kainos Group plc has repurchased 46,330 of its ordinary shares on 5 January 2026 ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Hays plc ( ...

On 10 June 2025 FirstGroup plc (the ‘Group’) announced an on-market share buyback programme to purchase up to £50m of ordinary shares (the ’Programme’), which commenced on 10 June 2025. The Group ...